In 2023, Germany led global hypnotic and sedative medicine sales with $111.7 million, showing a growth of 3.08% year-on-year. In contrast, Croatia and Portugal saw declines of 0.64% and 1.54%, respectively. Chile exhibited a significant rise of 9.34%, while New Zealand experienced remarkable growth of 16.05%. Slovenia faced a decrease of 1.47%. Iceland also showed a positive trend with an increase of 6.32%. Over the past five years, increasing focus on mental health and aging populations have driven market growth, with varied impacts across regions.
Future trends to watch include the potential impact of healthcare policies on prescription habits, advancements in technology enhancing drug delivery and efficacy, and increasing emphasis on alternative therapies that may influence market dynamics globally. Monitoring regulatory changes and consumer preferences will be crucial for stakeholders in the coming years.
Top countries in Hypnotic and Sedative Medicine Sales by Country
| # | 10 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 111.7 | 2023 | 0% | +3.08% | View data |
| 2 | 2 Croatia | 43 | 2023 | +0.7% | -0.64% | View data |
| 3 | 3 Chile | 35 | 2023 | +3.55% | +9.34% | View data |
| 4 | 4 Portugal | 19.8 | 2023 | 0% | -1.54% | View data |
| 5 | 5 Denmark | 16.2 | 2023 | +0.62% | -0.61% | View data |
| 6 | 6 Slovakia | 9 | 2023 | +3.45% | +2.9% | View data |
| 7 | 7 Iceland | 7.2 | 2023 | +4.35% | +6.32% | View data |
| 8 | 8 New Zealand | 4 | 2023 | +2.56% | +16.05% | View data |
| 9 | 9 Estonia | 3 | 2023 | +7.14% | +2.9% | View data |
| 10 | 10 Slovenia | 2.6 | 2023 | 0% | -1.47% | View data |
